Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.
Saved in:
| Title: | Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics. |
|---|---|
| Authors: | Li A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Keck JM; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Center for Spatial Systems Biomedicine (OCSSB),Oregon Health and Science University, Portland, OR, USA., Parmar S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Patterson J; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Labrie M; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Creason AL; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Johnson BE; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Center for Spatial Systems Biomedicine (OCSSB),Oregon Health and Science University, Portland, OR, USA.; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA., Downey M; Department of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, USA., Thomas G; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Pathology, Oregon Health and Science University, Portland, OR, USA., Beadling C; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Heiser LM; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA., Kolodzie A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Center for Spatial Systems Biomedicine (OCSSB),Oregon Health and Science University, Portland, OR, USA., Guimaraes AR; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, USA.; Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USA., Corless CL; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Pathology, Oregon Health and Science University, Portland, OR, USA., Gray JW; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Center for Spatial Systems Biomedicine (OCSSB),Oregon Health and Science University, Portland, OR, USA.; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA., Mills GB; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USA.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bergan RC; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Mitri ZI; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. mitri@ohsu.edu. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2021 Mar 26; Vol. 5 (1), pp. 28. Date of Electronic Publication: 2021 Mar 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-021-00165-4 |
